Phase I study of LY3866288, a potent, highly isoform-selective FGFR3 inhibitor in FGFR3-altered advanced solidtumors (FORAGER-1): Dose optimization
Drakaki, A.;
Park, S. H.;
Gauna, D. E. Castellano;
Siefker-Radtke, A. O.;
Reimers, M. A.;
외 15명
Citations
WEB OF SCIENCE
0
Citations
SCOPUS
0
제목
Phase I study of LY3866288, a potent, highly isoform-selective FGFR3 inhibitor in FGFR3-altered advanced solidtumors (FORAGER-1): Dose optimization
저자
Drakaki, A.; Park, S. H.; Gauna, D. E. Castellano; Siefker-Radtke, A. O.; Reimers, M. A.; Gao, X.; Rha, S. Y.; Galsky, M. D.; Tripathi, A.; Sarfaty, M.; Mamtani, R.; Zhang, T.; Sonpavde, G. P.; Vinceneux, A.; Loriot, Y.; Garmezy, B.; Szymczak, S.; Zhang, Z.; Widau, R.; Iyer, G.